Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/2014
09/18/2014WO2014144087A1 Sovaprevir polymorphs and methods of manufacture thereof
09/18/2014WO2014144075A1 Anticholinergic glycopyrrolate esters for the treatment of hyperhidrosis
09/18/2014WO2014144073A2 Augmenting moieties for anti-inflammatory compounds
09/18/2014WO2014144066A1 Drug delivery devices and methods for drug delivery
09/18/2014WO2014144064A2 1,4-disubstituted piperidines, 1,4-disubstituted piperazines, 1,4-disubstituted diazepanes, and 1,3-disubstituted pyrrolidine compounds
09/18/2014WO2014144037A1 Lxr modulators
09/18/2014WO2014144017A2 Compositions and methods for treating conditions that affect epidermis
09/18/2014WO2014143999A1 Antibacterial compounds
09/18/2014WO2014143992A1 Treating lysosomal storage disease
09/18/2014WO2014143985A1 Non-peptide bdnf neurotrophin mimetics
09/18/2014WO2014143964A2 Novel analgesic compositions
09/18/2014WO2014143960A1 Tetrahydroisoquinolin-2-yl-(quinazolin-4-yl) methanone compounds as cancer cell growth inhibitors
09/18/2014WO2014143943A1 Preparations containing hepatocyte growth factor and hyaluronic acid, and methods of making and using same
09/18/2014WO2014143941A1 Stabilized modified release vitamin d formulation and method of administring same
09/18/2014WO2014143935A1 Rapidly dispersible dosage form of oxcarbazepine
09/18/2014WO2014143898A1 Systems, devices, and methods for treating a pulmonary disorder with an agent
09/18/2014WO2014143857A1 System and method for hazardous drug surface cleaning
09/18/2014WO2014143845A1 Ready-to-use co-solvents pharmaceutical composition in modified flexible plastic container
09/18/2014WO2014143839A1 High drug load buprenorphine microspheres and method of producing the same
09/18/2014WO2014143835A1 Combination/adjuvant therapy for wt-1-positive disease
09/18/2014WO2014143806A1 Acid stable liposomal compositions
09/18/2014WO2014143768A1 Tricyclic heterocycles as bet protein inhibitors
09/18/2014WO2014143672A1 Macrocyclic compounds as irak4 inhibitors for the treatment of inflammatory diseases
09/18/2014WO2014143669A1 Compositions for use in treating heavy menstrual bleeding and uterine fibroids
09/18/2014WO2014143666A1 Hdac inhibitors
09/18/2014WO2014143659A1 Irreversible covalent inhibitors of the gtpase k-ras g12c
09/18/2014WO2014143646A1 Pharmaceutical composition of s-ketamine hydrochloride
09/18/2014WO2014143643A1 Acyclic nucleoside phosphonate diesters
09/18/2014WO2014143638A1 2-(1h-indol-4-ylmethyl)-3h-imidazo[4,5-b]pyridine-6-carbonitrile derivatives as complement factor b inhibitors useful for the treatment of ophthalmic diseases
09/18/2014WO2014143635A1 Compositions of a polyorthoester and an aprotic solvent
09/18/2014WO2014143630A1 Polymorph forms of desazadesferrithiocin analogs
09/18/2014WO2014143629A1 Bimatoprost for enhancement of leptin production
09/18/2014WO2014143625A1 Budiodarone formulations
09/18/2014WO2014143622A1 ACTIVATED CARBON FILTRATION FOR PURIFICATION OF BENZODIAZEPINE ADCs
09/18/2014WO2014143617A1 Deuterium-enriched tanaproget and processes for its preparation
09/18/2014WO2014143614A1 Lipid compositions containing bioactive fatty acids
09/18/2014WO2014143613A1 Methods of treatment of pediatric solid tumor
09/18/2014WO2014143612A1 6-[4-(1 h-imidazol-2-yl)piperidin-1 -yl]pyrimidin-4-amine derivatives as modulators of kinase activity
09/18/2014WO2014143610A1 Pyrrolotriazines as potassium ion channel inhibitors
09/18/2014WO2014143609A1 Isoquinolines as potassium ion channel inhibitors
09/18/2014WO2014143608A1 Phthalazines as potassium ion channel inhibitors
09/18/2014WO2014143607A1 Pyrrolopyridazines as potassium ion channel inhibitors
09/18/2014WO2014143606A1 Pyrrolotriazines as potassium ion channel inhibitors
09/18/2014WO2014143592A1 Inhibition of neovascularization by inhibition of prostanoid ip receptors
09/18/2014WO2014143591A1 Inhibition of neovascularization by simultaneous inhibition of prostanoid ip and ep4 receptors
09/18/2014WO2014143579A1 Tetrahydropyrrolothiazine compounds
09/18/2014WO2014143576A1 A composition comprising mannoheptulose for use in the treatment or prevention of overweight and obesity
09/18/2014WO2014143561A1 Ship1 modulators and methods related thereto
09/18/2014WO2014143539A1 Composition and method for preventing, reducing, alleviating, or treating idiopathic vomiting
09/18/2014WO2014143536A1 Extended release compositions comprising hydrocodone and acetaminophen for rapid onset and prolonged analgesia that may be administered without regard to food
09/18/2014WO2014143471A1 Oral electrolyte solution containing lactoferrin and uses thereof
09/18/2014WO2014143453A1 Phosphodiesterase inhibitor treatment
09/18/2014WO2014143275A1 Omega-3 pentaenoic acid compositions and methods of use
09/18/2014WO2014143272A1 Omega-3 pentaenoic acid compositions and methods of use
09/18/2014WO2014143242A1 Compounds useful as inhibitors of atr kinase
09/18/2014WO2014143241A1 Compounds useful as inhibitors of atr kinase
09/18/2014WO2014143240A1 Fused pyrazolopyrimidine derivatives useful as inhibitors of atr kinase
09/18/2014WO2014143201A1 Method for noribogaine treatment of addiction in patients on methadone
09/18/2014WO2014143146A1 Methods of administering monomethyl fumarate
09/18/2014WO2014143127A1 Emulsion formulations
09/18/2014WO2014143125A1 Use of indole compounds for fat reduction and skin and soft tissue tightening
09/18/2014WO2014143107A1 Methods of treating, reducing the incidence of, and/or preventing ischemic events
09/18/2014WO2014143051A1 Fluorinated pyrimidine analogs and methods of use thereof
09/18/2014WO2014143031A1 Compositions and methods including celecoxib and plumbagin relating to treatment of cancer
09/18/2014WO2014142995A1 Compositions and methods including leelamine and arachidonyl trifluoromethyl ketone relating to treatment of cancer
09/18/2014WO2014142938A1 Pharmaceutical formulation containing glycosaminoglycan
09/18/2014WO2014142915A1 Methods for producing a biodegradable chitosan composition and uses thereof
09/18/2014WO2014142780A1 Methods of treating, reducing the incidence of, and/or preventing ischemic events
09/18/2014WO2014142757A1 Hybrid nanomaterial of graphene oxide nanomaterial and cationic quaternized chitosan
09/18/2014WO2014142748A1 Quorum sensing inhibitors
09/18/2014WO2014142705A1 A cytokine-containing drug having an antiviral, antimicrobial, immunomodulatory and anti-inflammatory effect for treating and prophylaxis of infectious diseases
09/18/2014WO2014142660A1 Combinations of inhibitors of mek, egfr and erbb2 in the treatment of kras-mutant lung cancer and kras-mutant colon cancer
09/18/2014WO2014142645A1 Antiviral activity of quercetin against japanese encephalitis virus
09/18/2014WO2014142644A1 Antiviral activity of baicalein against japanese encephalitis virus
09/18/2014WO2014142640A1 Improvements to the method for preparing hydroxocobalamin and the high-purity salts thereof
09/18/2014WO2014142616A1 Mosapride sustained-release preparation for providing pharmacological clinical effects with once-a-day administration
09/18/2014WO2014142607A1 Pharmaceutical combination drug
09/18/2014WO2014142574A1 Pharmaceutical formulation comprising lipase inhibitor having increased dissolution rate and reduced side effects, and method for preparing same
09/18/2014WO2014142550A1 Phenyl carbamate compound and a composition for preventing or treating a psychiatric disorder comprising the same
09/18/2014WO2014142549A1 Phenyl carbamate compound and a composition for preventing or treating a memory loss-related disease comprising the same
09/18/2014WO2014142548A1 Phenyl carbamate compound and a composition for preventing or treating a nerve gas-induced disease comprising the same
09/18/2014WO2014142547A1 Phenyl carbamate compound and a composition for neuroprotection comprising the same
09/18/2014WO2014142535A1 Composition for treating diabetes, containing phytoncide-derived isoprenoid
09/18/2014WO2014142521A1 Complex preparation including valsartan and rosuvastatin calcium and manufacturing method therefor
09/18/2014WO2014142520A1 Phenyl carbamate compounds for use in preventing or treating epilepsy or epilepsy-related syndrome
09/18/2014WO2014142519A1 Phenyl alkyl carbamate compounds for use in preventing or treating epilepsy or epilepsy-related syndrome
09/18/2014WO2014142518A1 Phenyl carbamate compounds for use in preventing or treating a movement disorder
09/18/2014WO2014142507A1 Composition for preventing or treating colon cancer, containing 3,6-anhydro-l-galactose
09/18/2014WO2014142477A1 Phenyl carbamate compounds for use in preventing or treating pediatric epilesy and epilesy-related syndromes
09/18/2014WO2014142363A1 Spiro azetidine isoxazole derivatives and their use as sstr5 antagonists
09/18/2014WO2014142322A1 Benzothiophene derivative
09/18/2014WO2014142298A1 Novel hydroxamic acid derivative or salt thereof
09/18/2014WO2014142292A1 Fused heterocyclic compound or salt thereof, agricultural and horticultural insecticide containing fused heterocyclic compound, and method for using agricultural and horticultural insecticide
09/18/2014WO2014142291A1 Hydrate of fluorine compound, and crystals thereof
09/18/2014WO2014142290A1 Pyrazole-amide compound and medicinal uses therefor
09/18/2014WO2014142276A1 4-hydroperoxy-trans-2-decenoic acid derivative and medicine containing same
09/18/2014WO2014142273A1 Dihydropyridazine-3,5-dione derivative
09/18/2014WO2014142255A1 Heterocyclic compound
09/18/2014WO2014142221A1 Drug for respiratory diseases
09/18/2014WO2014142220A1 Anti-tumor agent
1 ... 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 ... 7860